tiprankstipranks
Trending News
More News >

MaxCyte Announces Change in Major Holdings by BlackRock

Story Highlights
MaxCyte Announces Change in Major Holdings by BlackRock

Confident Investing Starts Here:

The latest update is out from MaxCyte ( (MXCT) ).

MaxCyte, Inc. has announced a change in major holdings, with BlackRock, Inc. now holding 7.90% of voting rights, up from a previous 7.80%. This adjustment in BlackRock’s stake reflects a slight increase in their influence within the company, potentially impacting MaxCyte’s strategic decisions and signaling confidence from a major institutional investor.

More about MaxCyte

MaxCyte, Inc. operates in the biotechnology industry, focusing on cell engineering and providing cell-based therapies. The company is known for its proprietary cell engineering platform that supports a wide range of applications, including drug discovery and development, biomanufacturing, and cell therapy.

Find detailed analytics on MXCT stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1